This study is for adults with Inflammatory Bowel Disease (IBD), like Crohn's Disease or Ulcerative Colitis, which are conditions causing inflammation in the digestive tract. It's a Phase 2 study, meaning researchers are checking how safe and effective new treatments are. They will test different medicines, some you take by mouth (oral) and some given through a needle (parenteral). The study will check how these medicines work in the body (pharmacokinetics) and what they do to the body (pharmacodynamics). To join, you must have been diagnosed with Crohn's Disease or Ulcerative Colitis by a doctor. Also, your disease needs to be moderately to severely active. If you previously had major surgeries or certain severe conditions, you might not be able to join.

• **Length of Study**: The study period and number of visits are not specified.
• **Risks**: Participation involves taking experimental medicines whose safety is still being tested.
• **Compensation**: The study does not mention any compensation for participants.